{
  "template_type": "Tree of Thought Template",
  "prompts": [
    {
      "id": "TT1",
      "prompt": "How can we improve the catalytic efficiency of CYP3A4 for drug metabolism?",
      "guiding_questions": [
        "What are the key structural features of CYP3A4 that influence its catalytic efficiency in drug metabolism?",
        "How do specific amino acid residues in CYP3A4 affect its performance with various drug substrates?",
        "What site-directed mutagenesis strategies could be used to enhance the catalytic efficiency of CYP3A4?",
        "What structural modifications in CYP3A4 are needed to support these genetic changes for improved drug metabolism?",
        "How can computational modeling assist in predicting the effects of these modifications on CYP3A4’s catalytic activity?",
        "What experimental assays can be used to measure the impact of these modifications on drug metabolism?",
        "What potential advantages could arise from improving CYP3A4's efficiency for pharmaceutical applications?",
        "How can these optimized CYP3A4 variants be scaled up for use in industrial drug metabolism processes?"
      ]
    },
    {
      "id": "TT2",
      "prompt": "How can we enhance the stability of CYP3A4 under extreme environmental conditions?",
      "guiding_questions": [
        "What are the specific structural and biochemical factors contributing to CYP3A4 instability in extreme temperatures or pH levels?",
        "How do extreme environmental conditions affect the stability and function of CYP3A4?",
        "What genetic modifications could enhance the stability of CYP3A4 under these extreme conditions?",
        "What structural changes are crucial for maintaining CYP3A4 stability and function in harsh environments?",
        "How can we apply protein engineering techniques to introduce these stability-enhancing features into CYP3A4?",
        "What experimental methods are effective for assessing the stability of CYP3A4 under extreme conditions?",
        "What impact would improved stability have on the use of CYP3A4 in industrial processes?"
      ]
    },
    {
      "id": "TT3",
      "prompt": "How can we optimize the substrate specificity of CYP3A4 for targeted drug synthesis?",
      "guiding_questions": [
        "What specific amino acid residues in CYP3A4 determine its substrate specificity for targeted drugs?",
        "How can site-directed mutagenesis be used to alter CYP3A4’s substrate binding sites to improve specificity?",
        "What structural modifications are required to enhance CYP3A4's interaction with specific drug substrates?",
        "How can protein engineering be used to achieve these modifications and improve substrate specificity?",
        "What biochemical assays can be employed to evaluate changes in substrate specificity of engineered CYP3A4?",
        "How will these modifications affect the efficiency and selectivity of drug synthesis processes?",
        "What challenges might arise when scaling up the use of these modified CYP3A4 enzymes for industrial applications?"
      ]
    },
    {
      "id": "TT4",
      "prompt": "How can we address CYP3A4 enzyme degradation during long-term industrial use?",
      "guiding_questions": [
        "What are the specific causes of CYP3A4 degradation over time during continuous industrial use?",
        "How do factors like enzyme concentration, reaction conditions, and exposure to inhibitors contribute to CYP3A4 degradation?",
        "What strategies can be employed to minimize degradation of CYP3A4 during extended use in industrial processes?",
        "How can genetic modifications or structural changes improve CYP3A4's durability and resistance to degradation?",
        "What experimental designs can evaluate the effectiveness of these durability-enhancing strategies?",
        "How does improving CYP3A4’s durability impact the overall efficiency and cost-effectiveness of industrial biocatalysis?"
      ]
    },
    {
      "id": "TT5",
      "prompt": "How can we enhance CYP3A4 enzyme activity for biotransformations in green chemistry applications?",
      "guiding_questions": [
        "What specific properties of CYP3A4 influence its activity in biotransformations for green chemistry applications?",
        "How can these properties be optimized to make CYP3A4 more effective in environmentally friendly chemical processes?",
        "What genetic modifications can enhance CYP3A4 activity for specific biotransformations in green chemistry?",
        "What structural adaptations can be made to improve CYP3A4 performance in these applications?",
        "How can protein engineering be applied to achieve these adaptations?",
        "What methods can validate the enhanced activity of CYP3A4 in green chemistry biotransformations?",
        "What benefits could these enhancements bring to sustainable chemical processes and practices?"
      ]
    },
    {
      "id": "TT6",
      "prompt": "How can we improve CYP3A4 enzyme performance in solvent-rich industrial environments?",
      "guiding_questions": [
        "What are the key challenges faced by CYP3A4 in solvent-rich industrial environments?",
        "How do the properties of different solvents affect CYP3A4’s stability and activity?",
        "What genetic or structural modifications can enhance CYP3A4’s performance in solvent-rich conditions?",
        "What protein engineering techniques are best suited for optimizing CYP3A4 for these environments?",
        "How can synthetic biology tools aid in improving CYP3A4’s functionality in solvent-rich environments?",
        "What methods can be used to test and validate the performance of CYP3A4 in these conditions?",
        "What potential impacts will these improvements have on industrial processes involving solvent-rich environments?"
      ]
    },
    {
      "id": "TT7",
      "prompt": "How can we enhance the selectivity of CYP3A4 for complex organic compounds?",
      "guiding_questions": [
        "What are the key determinants of CYP3A4’s selectivity for complex organic compounds?",
        "How can specific interactions between CYP3A4 and these compounds be optimized?",
        "What genetic modifications can improve CYP3A4’s selectivity for complex organic substrates?",
        "What structural features are critical for achieving high selectivity in CYP3A4?",
        "How can protein engineering techniques be employed to modify these features?",
        "What experimental approaches can test the improved selectivity of engineered CYP3A4?",
        "What challenges might arise when scaling up the use of these enhanced enzymes in industrial applications?"
      ]
    },
    {
      "id": "TT8",
      "prompt": "How can we improve CYP3A4 enzyme performance in low-temperature industrial processes?",
      "guiding_questions": [
        "What specific challenges does CYP3A4 face when used in low-temperature conditions?",
        "How do low temperatures impact the activity and stability of CYP3A4?",
        "What genetic or structural modifications can enhance CYP3A4’s performance at low temperatures?",
        "How can protein engineering techniques be applied to achieve these modifications?",
        "What experimental designs are effective for testing CYP3A4 performance in low-temperature environments?",
        "What are the implications of improved enzyme performance for industrial processes operating at low temperatures?"
      ]
    },
    {
      "id": "TT9",
      "prompt": "How can we address the issue of CYP450 enzyme inhibition in industrial processes?",
      "guiding_questions": [
        "What are the common causes of CYP3A4 inhibition in industrial processes?",
        "How do specific inhibitors interact with CYP3A4 to affect its catalytic activity?",
        "What genetic or structural modifications can reduce the susceptibility of CYP3A4 to inhibition?",
        "What protein engineering techniques can be used to address this inhibition issue?",
        "What methods can be employed to test the effectiveness of these modifications in reducing inhibition?",
        "What benefits could reducing CYP3A4 inhibition bring to industrial processes and overall efficiency?"
      ]
    },
    {
      "id": "TT10",
      "prompt": "How can we enhance the reusability of CYP3A4 in industrial biocatalysis?",
      "guiding_questions": [
        "What factors affect the reusability of CYP3A4 in industrial biocatalysis processes?",
        "How can we maintain enzyme stability and activity over multiple use cycles?",
        "What genetic or structural modifications can improve the reusability of CYP3A4?",
        "What protein engineering techniques are effective in enhancing enzyme reusability?",
        "What experimental designs can evaluate the reusability of these modified CYP3A4 enzymes?",
        "What potential benefits does enhanced reusability offer for industrial biocatalysis processes?"
      ]
    }
  ]
}
